皮肤伤害性感觉神经元分布异常驱动表皮角质形成细胞过度增殖的机制研究OA
Mechanisms of Aberrant Cutaneous Nociceptive Innervation Driving Epidermal Keratinocyte Hyperproliferation
目的 比较神经性皮炎皮损与正常人皮肤中伤害性感觉神经元的丰度与分布,体外观察重组降钙素基因相关肽(CGRP)对人角质形成细胞(KCs)增殖及相关信号分子变化的影响.方法 选取本院 2024 年 1 月—2025 年1 月收治的 5 例神经性皮炎患者皮损组织,以 5 例年龄、性别相匹配的整形手术边缘正常皮肤为对照.每例切取约0.5 cm×0.5 cm 组织,液氮速冻后-80℃保存,分为神经性皮炎组与正常对照组.用双重免疫荧光染色检测 P 物质(SP)、CGRP 及瞬时受体电位香草酸亚型 1(TRPV1)在神经性皮炎皮损与正常皮肤中的表达;培养人原代 KCs,用重组CGRP 和瑞美吉泮(一种CGRP 受体拮抗剂)处理,蛋白质印迹法(Western blotting)检测细胞增殖标记分子(PCNA)以及磷酸化 p38 丝裂原活化蛋白激酶(p-p38 MAPK)和磷酸化细胞外调节蛋白激酶 1/2(ERK1/2)水平;用 2,4-二硝基氯苯(DNCB)外涂小鼠耳郭建立慢性皮炎模型,同时给予瑞美吉泮灌胃治疗干预.采用苏木精-伊红(HE)染色和蛋白质印迹法分别检测表皮厚度与 PCNA 表达水平.结果 与正常人皮肤比较,神经性皮炎皮损中 SP+、CGRP+及TRPV1+感觉神经纤维分布及丰度明显增加,差异有统计学意义(P<0.05);体外细胞试验表明 CGRP 处理上调 KCs 的PCNA 蛋白表达,差异有统计学意义(P<0.05),且 p38-ERK1/2 信号分子发生磷酸化;动物试验结果显示瑞美吉泮治疗组小鼠较单纯 DNCB 处理组表皮厚度显著变薄,差异有统计学意义(P<0.05),且皮肤组织中的 CGRP 和 PCNA 蛋白表达也降低.结论 皮肤中异常分布的伤害性感觉神经元可释放神经肽(如 SP 和 CGRP),并可直接诱导 KCs 增殖.瑞美吉泮是否能够缓解神经性皮炎瘙痒和表皮增殖,有待临床进一步验证.
Objective In order to compare the abundance and innervation of nociceptive sensory neurons in lesional neurodermatitis skin versus normal human skin,and to investigate the effects of recombinant calcitonin gene-related peptide(CGRP)neuropeptide on the proliferation of cultured keratinocytes(KCs)and the changes of signaling molecules involved.Methods Lesional skin from five neurodermatitis patients(admitted from January 2024 to January 2025)and normal control skin from five age-and sex-matched plastic surgery margins were collected.Tissue samples(0.5 cm×0.5 cm)were excised,snap-frozen in liquid nitrogen,and stored at-80℃.Samples were divided into a neurodermatitis group and a normal control group.The expression of substance P(SP),CGRP and transient receptor potential vanilloid 1(TRPV1)in lesional skin of neurodermatitis and normal skin was evaluated using double immunofluorescence staining.Human primary KCs were cultured from foreskin tissue and treated with recombinant CGRP neuropeptide or rimegepant(a CGRP receptor antagonist).Western blotting assay was carried out to measure the levels of proliferating cell nuclear antigen(PCNA)and phosphorylated p38 mitogen-activated protein kinase(p-p38 MAPK),and phosphorylated extracellular signal-regulated kinase 1/2(p-ERK1/2).A chronic dermatitis model was established by topical application of dinitrochlorobenzene(DNCB)onto the ear skin of mice,combined with intragastric administration of rimegepant for intervention.Hematoxylin-eosin(HE)staining and Western blotting were used to assess epidermal thickness and PCNA expression level,respectively.Results As compared with normal human skin,neurodermatitis lesions showed a significant increase in the abundance and innervation of SP+,CGRP+and TRPV1+sensory nerve fibers(P<0.05).Meanwhile,the CGRP treatment upregulated PCNA protein expression in cultured KCs and elevated the levels of p-p38 and p-ERK1/2(P<0.05).Animal studies showed that the rimegepant-treated group had a significant reduction in both epidermal thickness and the expression of CGRP and PCNA proteins in skin tissues compared with the DNCB-only group(P<0.05).Conclusion Abnormally increased nociceptive sensory neurons in the skin exacerbate pruritus by releasing neuropeptides such as SP and CGRP,and also stimulate KCs proliferation.The potential of rimegepant in treating or alleviating pruritus and epidermal hyperproliferation in neurodermatitis warrants further clinical investigation.
叶楚环;雷铁池
武汉大学人民医院,湖北 武汉 430060武汉大学人民医院,湖北 武汉 430060
医药卫生
伤害性感觉神经元降钙素基因相关肽细胞增殖角质形成细胞神经性皮炎
Nociceptive sensory neuronsCalcitonin gene-related peptideCell proliferationKeratinocytesNeurodermatitis
《中国中西医结合皮肤性病学杂志》 2026 (4)
294-300,7
国家自然科学基金面上项目(编号:82273513).
评论